Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Brem

Showing results (261-270 of 291) with videos related to

Pageof 30
Sort By:
Journal for Immunotherapy of Cancer|May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and VaccinationChristopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.
Journal for Immunotherapy of Cancer|November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
International Journal of Cancer|August 3, 2019
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer typesDimitrios Mathios, Taeyoung Hwang, Yuanxuan Xia, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Brain : a Journal of Neurology|October 25, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasisSahar Israeli Dangoor, Rami Khoury, Koren Salomon, et al.
Journal of Neuro-Oncology|October 30, 2025
The relationship between extent of resection, tumor recurrence, and facial nerve outcomes in vestibular schwannoma surgery: a single-institution experience and systematic reviewSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Drug Delivery and Translational Research|January 4, 2026
Intraoperative drug delivery to hindbrain tumours via an injectable hydrogel is well tolerated and confers survival benefit against atypical teratoid/rhabdoid xenograftsCara Moloney, Phoebe McCrorie, Amr ElSherbeny, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaJennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Pageof 30

Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Journal for Immunotherapy of Cancer|May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and VaccinationChristopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.
Journal for Immunotherapy of Cancer|November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
International Journal of Cancer|August 3, 2019
Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer typesDimitrios Mathios, Taeyoung Hwang, Yuanxuan Xia, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Brain : a Journal of Neurology|October 25, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasisSahar Israeli Dangoor, Rami Khoury, Koren Salomon, et al.
Journal of Neuro-Oncology|October 30, 2025
The relationship between extent of resection, tumor recurrence, and facial nerve outcomes in vestibular schwannoma surgery: a single-institution experience and systematic reviewSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Drug Delivery and Translational Research|January 4, 2026
Intraoperative drug delivery to hindbrain tumours via an injectable hydrogel is well tolerated and confers survival benefit against atypical teratoid/rhabdoid xenograftsCara Moloney, Phoebe McCrorie, Amr ElSherbeny, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaJennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Pageof 30